Actemra Pen

• Have moderate to severe rheumatoid arthritis and have not responded well to other medications.
• Suffer from polyarticular juvenile idiopathic arthritis or systemic juvenile idiopathic arthritis.
• Are diagnosed with giant cell arteritis.
• Need a treatment that can help manage chronic inflammation and symptoms associated with these conditions.

How is Actemra Pen taken?

Actemra Pen is taken as an injection under the skin. The injection can be administered in the abdomen, thigh, or upper arm. Your doctor or nurse will show you how to use the pen. The frequency of the injections depends on the condition being treated and the dosage prescribed by your healthcare provider.

What to know when taking Actemra Pen?

• How to Use: Follow the instructions from your doctor or nurse on how to inject Actemra Pen.
• Storage: Keep the Actemra Pen in the refrigerator until you are ready to use it. Do not freeze the medication.
• Side Effects: Common side effects include injection site reactions, upper respiratory tract infections, headache, and high blood pressure. Report any unusual or severe symptoms to your doctor.
• Monitoring: Regular blood tests may be needed to monitor your body’s response to the medication and to check for potential side effects.

Medication Warnings

• Infections: Actemra Pen can lower the ability of your immune system to fight infections. Report any signs of infection such as fever, chills, or persistent cough to your doctor immediately.
• Liver Problems: The medication can cause liver problems. Regular monitoring of liver function is recommended.
• Gastrointestinal Perforations: There is a risk of gastrointestinal perforations, especially in patients with a history of diverticulitis. Seek immediate medical attention if you experience severe stomach pain.
• Allergic Reactions: If you have symptoms like a rash, itching, swelling, dizziness, or trouble breathing, get medical help right away.
• Lab Tests: Regular blood tests may be needed to monitor your health while taking Actemra Pen.

Suitable Candidates:

• Individuals with specific autoimmune diseases who need targeted immunosuppressive treatment.
• Patients who have not adequately responded to standard treatments.

Unsuitable Candidates:

• Individuals with active, severe infections.
• Patients with a history of severe allergic reactions to tocilizumab or any component of the Actemra Pen.
• Those with a known history of diverticulitis due to the increased risk of gastrointestinal perforation.

For more detailed information and personalized advice, consult your healthcare provider.